Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 8-K Event Regulation FD disclosure
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 4 Insider Changes in Ownership
  8. 8-K Event Regulation FD disclosure
  9. 8-K Event Material agreement
  10. 8-K Event Other events
  11. 424B5 Offering Prospectus
  12. 8-K Event Other events
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 3/A Insider 3/A
  17. 3/A Insider 3/A
  18. 3/A Insider 3/A
  19. 8-K Event Regulation FD disclosure
  20. SC 13D/A Stake Beneficial Ownership Report

Page 15 of 27 · 537 filings